• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Andra medicinska specialiteter
    3. Farmakologi

    Systemic Drug Delivery Strategies

    Volume 2 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy

    AvMansoor M. Amiji,Lara Scheherazade Milane

    Häftad, Engelska, 2021

    2 022 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Systemic Drug Delivery Strategies: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy, Volume 2 examines the challenges of delivering immuno-oncology therapies, focusing specifically on the multiple technologies of affective drug delivery strategies. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. This volume of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy discusses methods of targeting tumors, CRISPR technology, and vaccine delivery among many other delivery strategies.

    Systemic Drug Delivery Strategies: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy, Volume 2 creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side.



    • Comprehensive treaty covering all aspects of immuno-oncology (IO)
    • Novel strategies for delivery of IO therapeutics and vaccines
    • Forecasting on the future of nanotechnology and drug delivery for IO

    Produktinformation

    • Utgivningsdatum:2021-08-26
    • Mått:191 x 235 x undefined mm
    • Vikt:450 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:588
    • Förlag:Elsevier Science
    • ISBN:9780323857819

    Utforska kategorier

    • Farmakologi inom Medicin
    • Biokemisk teknik inom Naturvetenskap och teknik
    • Tillverkningsindustri inom Ekonomi och Ledarskap

    Mer om författaren

    Mansoor M. Amiji is the Distinguished Professor and Chairman of the Department of Pharmaceutical Sciences at the Bouvé College of Health Sciences at Northeastern University. Dr. Amiji has edited a number of books and is a frequently published author. His research focuses on the synthesis of novel polymeric materials for medical and pharmaceutical applications, drug delivery systems and nanomedical technologies, and his contributions in research advising, grant reviews for various organizations and editorial work for journals are invaluable. Dr. Lara Milane is Assistant Teaching Professor in Biotechnology at the Bouvé College of Health Sciences at Northeastern University. She is interested in Mitochondrial Medicine. She is working on developing nanomedicines for a range of diseases (cancer, neurodegenerative disease, aging) that manipulate mitochondria for therapeutic outcomes. Dr. Milane was trained as a National Cancer Institute/ National Science Foundation Nanomedicine Fellow at Northeastern University, Boston, MA. Dr. Milane is an intuitive cancer biologist with research interests in developing translational nanomedicines that exploit the hallmarks of cancer.

    Innehållsförteckning

    • 1. Delivery strategies for immune checkpoint blockade inhibitors2. Delivery strategies for ex vivo and in vivo T-cell reprogramming3. Delivery strategies for ex vivo and in vivo NK cell reprogramming4. Delivery strategies for tumor-associated macrophage reprogramming5. Reprogramming lymphocytes for tumor immunotherapy6. Targeting tumor-associated neutrophils in immunotherapy7. Targeting tumor-associated fibroblast in immunotherapy8. Oncolytic viral particle delivery9. Extracellular vesicles (exosomes) in tumor immunotherapy10. Nucleic acid-based delivery and reprogramming for tumor immuno-oncology11. CRISPR-based gene editing in cancer immunotherapy12. Delivery strategies for glioma immunotherapy13. Delivery strategies for STING agonists14. Delivery strategies for cancer vaccine and immunoadjuvant15. Targeted delivery and reprogramming myeloid-derived suppressor cells (MDSC) in cancer16. Delivery of radio-immunotherapy for solid tumors17. Delivery of photo-immunotherapy for cancer18. Local immunotherapy of cancer and metastasis19. Delivery strategies to overcome tumor immunotherapy resistance